EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Selenoprotein P and selenium as potential diagnostic biomarkers for breast cancer patients

Farah A. Rashid, Rawaa A. Ali, Hanaa A. Ali

Karbala International Journal of Modern Science · 21.07.2026 · 12 (3)

DOI: 10.33640/2405-609x.3469 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Karbala International Journal of Modern Science, online erschienen am 21.07.2026. Verfasst von Farah A. Rashid und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer incidence increases in last decade. Oxidative stress increases during cancer development causes consuming of antioxidants. Selenium and its transporting protein, selenoprotein P have an important role in redox homeostasis. This study aims to investigate whether or not selenium and selenoprotein P could be diagnostic biomarkers for breast cancer patients. This study was included 30 individuals in control group who is age- and BMI-matched with 60 breast cancer patients. Selenium was measured by colorimetric assay kit and selenoprotein P was determined by Sandwich ELISA kits. The results indicate significant decrease (p < 0.0001) of serum selenium and selenoprotein P in breast cancer patients compared to control. A positive significant correlation (r = 0.6214, p < 0.0001) was found between selenium and selenoprotein P in breast cancer patients. Selenium has an excellent diagnostic accuracy with area under curve 0.9831, sensitivity 95% and specificity 100% at cut-off less than 3.54 mmol/L. Furthermore, selenoprotein P has also an excellent area under curve 0.9958 with sensitivity 96.77% and specificity 100% at cut-off less than 4.15 ng/ml. These exploratory findings appear that selenium and selenoprotein P could be potential diagnostic biomarkers for breast cancer patients. Further investigations in large-multicenter populations are needed to confirm results.

Zitieren

APA

Rashid, F. A., Ali, R. A., & Ali, H. A. (2026). Selenoprotein P and selenium as potential diagnostic biomarkers for breast cancer patients. Karbala International Journal of Modern Science, 12(3). https://doi.org/10.33640/2405-609x.3469

Vancouver

Rashid FA, Ali RA, Ali HA. Selenoprotein P and selenium as potential diagnostic biomarkers for breast cancer patients. Karbala International Journal of Modern Science. 2026;12(3). doi:10.33640/2405-609x.3469

BibTeX
@article{Rashid2026,
  author = {Rashid, Farah A. and Ali, Rawaa A. and Ali, Hanaa A.},
  title = {Selenoprotein P and selenium as potential diagnostic biomarkers for breast cancer patients},
  journal = {Karbala International Journal of Modern Science},
  year = {2026},
  volume = {12},
  number = {3},
  doi = {10.33640/2405-609x.3469}
}
Kostenlos starten →